Dupilumab relieves pruritus both in uremic pruritus and in atopic dermatitis with chronic kidney disease: a retrospective real-world study
Dupilumab safely and effectively reduced pruritus in UP patients in the short term and achieved a comparable anti-pruritus effect to AD patients with CKD.
Authors
- Lixia Zhang (ORCID: https://orcid.org/0000-0001-9648-3219)
- Xiang Zhong (ORCID: https://orcid.org/0000-0003-2571-191X)
- Xiyuan Zhou (ORCID: https://orcid.org/0000-0003-3125-4700)
- Qian Wang (ORCID: https://orcid.org/0000-0002-4171-9738)
- Jie Liu (ORCID: https://orcid.org/0000-0001-6738-4801)
- Ge Yang (ORCID: https://orcid.org/0000-0003-3191-3083)
Institutions
- University of Electronic Science and Technology of China (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-09-10
- DOI
- https://doi.org/10.3389/fmed.2025.1627955
- Citations
- 3
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 6.01